Literature DB >> 23919748

Omega-3 polyunsaturated fatty acids and cancer.

Kaipeng Jing1, Tong Wu, Kyu Lim.   

Abstract

While the anticancer effect of omega-3 polyunsaturated fatty acids (omega-3 fatty acids), particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), has been the subject of intense study, our understanding regarding the underlying mechanisms of omega-3 fatty acids against cancer is still limited. Recent studies describing the cancer protective effect of EPA and DHA have sparked a renewed interest in using these fatty acids for cancer prevention and treatment. Here, we summarize the significance of omega- 3 fatty acids in the initiation and progression of cancer, and review the complex mechanisms by which EPA and DHA are thought to have anticancer activities during cancer development. It is concluded that omega-3 fatty acids may exert their anticancer actions by influencing multiple targets implicated in various stages of cancer development, including cell proliferation, cell survival, angiogenesis, inflammation, metastasis and epigenetic abnormalities that are crucial to the onset and progression of cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23919748     DOI: 10.2174/18715206113139990319

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  28 in total

Review 1.  Prostaglandin E3 metabolism and cancer.

Authors:  Peiying Yang; Yan Jiang; Susan M Fischer
Journal:  Cancer Lett       Date:  2014-03-18       Impact factor: 8.679

2.  Mechanisms by Which Pleiotropic Amphiphilic n-3 PUFA Reduce Colon Cancer Risk.

Authors:  Robert S Chapkin; Vanessa DeClercq; Eunjoo Kim; Natividad Roberto Fuentes; Yang-Yi Fan
Journal:  Curr Colorectal Cancer Rep       Date:  2014-12-01

3.  DHA-mediated regulation of lung cancer cell migration is not directly associated with Gelsolin or Vimentin expression.

Authors:  Mehboob Ali; Kathryn Heyob; Lynette K Rogers
Journal:  Life Sci       Date:  2016-05-05       Impact factor: 5.037

4.  In Vivo Antitumoral Effects of Linseed Oil and Its Combination With Doxorubicin.

Authors:  Oleg Shadyro; Anna Sosnovskaya; Irina Edimecheva; Lana Ihnatovich; Boris Dubovik; Sergei Krasny; Dmitry Tzerkovsky; Egor Protopovich
Journal:  Front Pharmacol       Date:  2022-06-21       Impact factor: 5.988

Review 5.  Health Benefits, Food Applications, and Sustainability of Microalgae-Derived N-3 PUFA.

Authors:  Yanjun Liu; Xiang Ren; Chao Fan; Wenzhong Wu; Wei Zhang; Yanwen Wang
Journal:  Foods       Date:  2022-06-25

6.  Docosahexanoic acid antagonizes TNF-α-induced necroptosis by attenuating oxidative stress, ceramide production, lysosomal dysfunction, and autophagic features.

Authors:  Fabio J Pacheco; Frankis G Almaguel; Whitney Evans; Leslimar Rios-Colon; Valery Filippov; Lai S Leoh; Elizabeth Rook-Arena; Melanie Mediavilla-Varela; Marino De Leon; Carlos A Casiano
Journal:  Inflamm Res       Date:  2014-08-06       Impact factor: 4.575

7.  Leucoselect Phytosome Modulates Serum Eicosapentaenoic Acid, Docosahexaenoic Acid, and Prostaglandin E3 in a Phase I Lung Cancer Chemoprevention Study.

Authors:  Jenny T Mao; Bingye Xue; Sili Fan; Patricia Neis; Clifford Qualls; Larry Massie; Oliver Fiehn
Journal:  Cancer Prev Res (Phila)       Date:  2021-03-11

8.  Supplementation with omega fatty acids increases the mRNA expression level of PLA2G4A in patients with gastric cancer.

Authors:  Donya Bazhan; Mahmoud Shekari Khaniani
Journal:  J Gastrointest Oncol       Date:  2018-12

Review 9.  Omega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed Evidence.

Authors:  Karsten H Weylandt; Simona Serini; Yong Q Chen; Hui-Min Su; Kyu Lim; Achille Cittadini; Gabriella Calviello
Journal:  Biomed Res Int       Date:  2015-08-02       Impact factor: 3.411

Review 10.  Mechanisms linking excess adiposity and carcinogenesis promotion.

Authors:  Ana I Pérez-Hernández; Victoria Catalán; Javier Gómez-Ambrosi; Amaia Rodríguez; Gema Frühbeck
Journal:  Front Endocrinol (Lausanne)       Date:  2014-05-01       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.